Press release
miRNA Tools and Services Market to Reach USD 7.0 Billion by 2034
miRNA Tools and Service
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73495
The growing recognition of miRNAs as biomarkers and therapeutic targets has fueled the demand for specialized tools and services for their analysis, profiling, and functional validation. From next-generation sequencing (NGS) kits and qPCR assays to bioinformatics services and custom oligonucleotide synthesis, the industry is expanding rapidly to meet diverse research and clinical needs.
According to Exactitude Consultancy, the miRNA Tools and Services Market was valued at USD 2.3 billion in 2024 and is projected to reach USD 7.0 billion by 2034, growing at a strong CAGR of 12.5% between 2025 and 2034. This exceptional growth highlights the expanding role of miRNAs in diagnostics, therapeutics, and personalized medicine.
Market Overview
• Market Size (2024): USD 2.3 billion
• Forecast (2034): USD 7.0 billion
• CAGR (2025-2034): 12.5%
Key Growth Drivers
• Rising demand for biomarker discovery in oncology and chronic diseases.
• Growing adoption of NGS and qPCR technologies for miRNA profiling.
• Increasing interest in miRNA-based therapeutics and drug development.
• Expanding bioinformatics capabilities for miRNA data analysis.
Key Challenges
• High cost of advanced sequencing and profiling platforms.
• Data complexity requiring specialized bioinformatics expertise.
• Regulatory hurdles for translating miRNA discoveries into clinical applications.
Major Players
Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, Exiqon (Qiagen subsidiary), Takara Bio, PerkinElmer, Norgen Biotek, and GeneCopoeia.
Segmentation Analysis
By Product Type
• Kits & Reagents
• Instruments (NGS Platforms, qPCR Systems, Microarrays)
• Services (Sequencing, Bioinformatics, Custom Oligos, Profiling)
• Others
By Technology
• qRT-PCR
• Next-Generation Sequencing (NGS)
• Microarrays
• In Situ Hybridization
• Immunoassays
• Others
By Application
• Oncology
• Neurology
• Cardiovascular Diseases
• Infectious Diseases
• Metabolic Disorders
• Stem Cell & Developmental Biology
• Others
By End User
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical & Diagnostic Laboratories
• Contract Research Organizations (CROs)
Segmentation Summary:
Kits and reagents dominate the market due to their recurring use in research, while NGS-based technologies are showing the fastest adoption. Oncology remains the largest application segment, as miRNAs are increasingly used in cancer biomarker discovery, diagnosis, and therapy monitoring. Bioinformatics services are also growing rapidly to address the complexity of miRNA datasets.
Explore Full Report here: https://exactitudeconsultancy.com/reports/73495/mirna-tools-and-services-market
Regional Analysis
North America
• Largest market share in 2024, led by the U.S.
• Strong adoption of miRNA profiling in cancer research and clinical trials.
• Presence of leading biotech and sequencing companies accelerates growth.
Europe
• Germany, UK, and France dominate regional adoption.
• EU-backed funding for genomics and precision medicine supports expansion.
• Growing collaborations between universities and biotech firms.
Asia-Pacific
• Expected to record the fastest CAGR through 2034.
• Expanding genomic research in China, Japan, South Korea, and India.
• Government investments in biotech infrastructure and clinical genomics.
Middle East & Africa
• Emerging adoption, primarily in research institutes.
• Limited infrastructure and funding are barriers to large-scale uptake.
Latin America
• Brazil and Mexico lead regional growth.
• Expanding biotech industry and increased participation in global clinical trials.
Regional Summary:
North America leads due to strong R&D and clinical integration, while Asia-Pacific is the fastest-growing region with significant investments in genomics and precision medicine. Europe maintains steady growth supported by strong academic research, while Latin America and the Middle East are gradually expanding with increased participation in international projects.
Market Dynamics
Growth Drivers
1. Expanding role of miRNAs as diagnostic and prognostic biomarkers.
2. Increasing demand for personalized medicine and targeted therapies.
3. Growth in research collaborations between academic institutions and biopharma companies.
4. Technological advances in sequencing, qPCR, and bioinformatics.
Key Challenges
1. High testing and data analysis costs.
2. Regulatory barriers for clinical approval of miRNA-based diagnostics and therapeutics.
3. Lack of standardized protocols for miRNA detection and analysis.
Latest Trends
• Development of liquid biopsy-based miRNA assays for cancer diagnostics.
• Integration of AI and machine learning in miRNA bioinformatics.
• Rising investment in miRNA therapeutics for cancer, cardiovascular, and neurological diseases.
• Expansion of single-cell miRNA analysis for deeper insights into disease biology.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73495
Competitive Landscape
Major Players
• Illumina
• Thermo Fisher Scientific
• Qiagen
• Agilent Technologies
• Bio-Rad Laboratories
• Exiqon (Qiagen)
• Takara Bio
• PerkinElmer
• Norgen Biotek
• GeneCopoeia
Competitive Dynamics
The market is innovation-driven, with companies focusing on developing advanced kits, sequencing platforms, and bioinformatics solutions. Leaders like Illumina and Thermo Fisher dominate sequencing and qPCR tools, while Qiagen and Agilent strengthen their positions in reagents and services. Smaller firms are carving niches in bioinformatics and custom oligonucleotide synthesis. Collaborations with pharma and biotech firms for therapeutic applications of miRNAs are also intensifying competition.
Conclusion
The miRNA Tools and Services Market is set for strong expansion, growing from USD 2.3 billion in 2024 to USD 7.0 billion by 2034, at a robust CAGR of 12.5%.
• Kits and reagents dominate usage, while NGS technologies and bioinformatics services are rapidly expanding.
• Oncology leads applications, but neurology and cardiovascular diseases are gaining attention.
• North America remains the largest market, while Asia-Pacific posts the fastest growth.
• Innovation in liquid biopsy assays, AI-driven analytics, and miRNA therapeutics will define the competitive landscape.
As miRNAs transition from research tools to clinical applications, the next decade will witness their growing integration into diagnostics, drug discovery, and precision medicine. This transformation will not only enhance disease management but also unlock new therapeutic possibilities, making miRNAs a cornerstone of modern molecular medicine.
This report is also available in the following languages : Japanese (miRNAツールおよびサービス市場), Korean (miRNA 도구 및 서비스 시장), Chinese (miRNA工具和服务市场), French (Marché des outils et services miRNA), German (Markt für miRNA-Tools und -Dienste), and Italian (Mercato degli strumenti e dei servizi miRNA), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/73495/mirna-tools-and-services-market#request-a-sample
Our More Reports:
Lambert-Eaton Myasthenic Syndrome Market
https://exactitudeconsultancy.com/reports/72902/lambert-eaton-myasthenic-syndrome-market
Hospital Acquired Pneumonia Market
https://exactitudeconsultancy.com/reports/72903/hospital-acquired-pneumonia-market
Human Factors and Usability Engineering Services Market
https://exactitudeconsultancy.com/reports/72904/human-factors-and-usability-engineering-services-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release miRNA Tools and Services Market to Reach USD 7.0 Billion by 2034 here
News-ID: 4184606 • Views: …
More Releases from Exactitude Consultancy
PFAS Testing Market to Double by 2034, Reaching USD 3.0 Billion
Per- and polyfluoroalkyl substances (PFAS), often referred to as "forever chemicals," have become a global environmental and public health concern due to their persistence, toxicity, and widespread use in industrial and consumer products. From firefighting foams to food packaging and textiles, PFAS are nearly indestructible, leading to contamination of soil, water, and even human bloodstreams.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73491
As governments, industries, and communities grapple with…
DNA Methylation Market to Reach USD 3.9 Billion by 2034
In recent years, the spotlight has increasingly turned toward epigenetics, the study of heritable changes in gene expression that occur without alterations in DNA sequences. Among the epigenetic mechanisms, DNA methylation has gained the most attention due to its crucial role in regulating gene activity, embryonic development, aging, and disease progression, particularly cancer.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73493
DNA methylation testing and analysis have become integral to…
Bioprocess Analyzers Market to Reach USD 5.1 Billion by 2034
The global biotechnology sector is advancing at record speed, driven by the rising demand for biologics, vaccines, and cell and gene therapies. Central to this transformation are bioprocess analyzers, which enable real-time monitoring and optimization of critical parameters in biomanufacturing. These systems ensure efficiency, product quality, and compliance in complex processes such as fermentation, cell culture, and protein production.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73497
According to Exactitude…
Single Cell Analysis Market to Reach USD 18.0 Billion by 2034
In modern life sciences and healthcare, the ability to understand biological processes at the single-cell level represents a major breakthrough. Traditional bulk analysis often masks cellular heterogeneity, while single cell analysis (SCA) technologies enable researchers to examine the unique genomic, transcriptomic, proteomic, and metabolic characteristics of individual cells. This is critical in fields like oncology, immunology, neurology, and regenerative medicine, where disease progression and treatment responses can vary significantly from…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
